Prostate Cancer Screening: To Screen or Not to Screen?
Author Information
Author(s): Rosser Charles J
Primary Institution: University of Florida
Conclusion
The debate over prostate cancer screening is shifting towards when to treat rather than whether to screen.
Supporting Evidence
- Prostate cancer survival improved in men who underwent screening and treatment compared to those who did not.
- Routine prostate cancer screening was associated with lower mortality rates than in years prior to PSA testing.
- Prostate cancer has been the second leading cause of cancer-related deaths in American men over 45 years.
Takeaway
This article discusses the ongoing debate about prostate cancer screening and emphasizes the need to focus on when to treat the disease.
Potential Biases
There is a risk of bias due to the low accrual of individuals of African descent in screening studies.
Limitations
The article highlights the lack of robust data on screening in African American men and the challenges in determining the causes of disparities in prostate cancer outcomes.
Participant Demographics
The article notes that African American men have a higher incidence and mortality rate from prostate cancer compared to Caucasian men.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website